1) idiopathic thrombocytopenia
特发性血小板减少
1.
Objective:to evaluate the clinical significance and change of the expression of T lymphocyte subtype in peripheral blood with idiopathic thrombocytopenia purpura patients.
目的:研究特发性血小板减少性紫癜患者外周血 T 淋巴细胞亚群的改变及其临床意义。
2) idiopathic thrombocytopenic
特发性血小板减少性
1.
Clincal evaluation of Partial Splenic Embolization for Treatment of Idiopathic Thrombocytopenic Purpura;
部分性脾栓塞治疗特发性血小板减少性紫癜的疗效观察
3) idiopathic thrombocytopenic purpura
特发性血小板减少紫癜
4) Idiopathic thrombocytopenic purpura
特发性血小板减少症
5) Acute idiopathic thrombocytopenic purpura
急性特发性血小板减少性紫癜
1.
Lymphoblastic PPAR-γ mRNA expression and the relevance with plasma IL-2 in children with acute idiopathic thrombocytopenic purpura
急性特发性血小板减少性紫癜患儿外周血淋巴细胞过氧化物酶体增生物活化受体γmRNA表达及其与血清白细胞介素-2的相关性
2.
Objective To investigate the number of CD4+CD25+ regulatory T cells and the level of related cytokines in peripheral blood of the children with acute idiopathic thrombocytopenic purpura(AITP),and analyze the relationship between CD4+CD25+ regulatory T cells and the immunopathogenesis of AITP.
目的检测急性特发性血小板减少性紫癜(ITP)患儿外周血CD4+CD25+调节性T细胞(TR)及相关细胞因子的变化,探讨它们在ITP发病机制中的作用。
6) Chronic idiopathic thrombocytopenic purpura
慢性特发性血小板减少性紫癜
1.
The aim of this study was to investigate the circulating levels of IL-11 in the patients with chronic idiopathic thrombocytopenic purpura (CITP), and its significance, and to evaluate the curative effect of rhIL-11 on CITP.
为了探讨慢性特发性血小板减少性紫癜(CITP)患者血清IL-11水平的动态变化及意义,研究重组人白细胞介素-11(rhIL-11)对CITP的治疗作用,采用ELISA方法对CITP患者治疗前后血清IL-11含量进行动态测定,并将rhIL-11应用于CITP患者,剂量1。
2.
In order to determine the curative effect of small dose heparin for treatment of chronic idiopathic thrombocytopenic purpura(CITP), a total of 12 CITP patients, who were failed with prednisone and immunosuppressants over 6 months, had been treated with subcutaneous injection of small dose heparin.
为了观察小剂量肝素对慢性特发性血小板减少性紫癜 (CITP)的临床疗效。
3.
Sixty six with chronic idiopathic thrombocytopenic purpura were randomly divided into group ( n =40) treated with purpura mixture,and control group ( n =26) treated with western medications (prednisone).
观察紫癜合剂治疗慢性特发性血小板减少性紫癜的疗效。
补充资料：特发性血小板减少性紫癜
| 特发性血小板减少性紫癜 idiopathic thrombocytopenic purpura 常见的免疫性血小板减少性紫癜。已证明多数ITP病人的血小板表面有抗自身血小板的抗体PAIgG ，其Fc段能被巨噬细胞的Fc受体所识别 ，主要在脾脏被单核-巨噬细胞吞噬而清除，所以ITP血小板寿命缩短，破坏过多，同时近年来亦发现ITP病人的巨核细胞与血小板有共同的抗原性 ，因而抗体也作用于巨核细胞，使之发育成熟延缓，结果使血小板生成减少。临床上分为急性和慢性两型，急性型以儿童多见，起病前多有感染史，出血症状重，但病程一般不超过半年，呈自限病程，可自然缓解；慢性型多见于中青年女性，多数说不清准确的起病日期，出血症状可轻可重，病程长，常反复发作。化验血小板计数＜100×109／L，可伴功能减低，骨髓中巨核细胞数正常或增多伴成熟型减少，PAIgG增高，在排除其他原因的血小板减少后即可诊断，特别应除外系统性红斑性狼疮引起者。ITP的治疗，除因出血严重者输新鲜血或血小板悬液外，首选皮质激素，80％病人有效，若疗效不满意时可加免疫抑制剂如长春新碱等，再无效时可切脾治疗，约3／4病人可完全恢复正常，其他疗法还有大剂量免疫球蛋白静脉输注，口服炔羟酮、氨肽素和大剂量维生素C等。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条